stockrow
Friday 6 November 2026
Export VREX’s income statement to Excel — free account
VAREX IMAGING
VREX Healthcare Medical Devices
VAREX IMAGING’s revenue for fiscal 2025 (year ended September 2025) was $844.6 million, up 4.14% from fiscal 2024.
- Revenue
- +3.69%
- EPS
- +117.2%
- Free cash flow
- +757.1%
- Total debt
- −5.55%
Quarter to June 2026, against a year earlier
18.45
0.01
+0.05%
Follow VREX
Alert me
VAREX IMAGING (VREX) P/E ratio
As of 5 November 2026, VAREX IMAGING (VREX) trades at a P/E ratio of 34.8×. Over the past ten years it has ranged from 0.0× (June 2026) to 221× (April 2020); the current reading is higher than 76% of that period. That is above the Medical Devices industry median of 25.6× and above the Healthcare sector median of 25.2×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 15.5× | (43.54%) |
| FY2022 | 27.5× | (56.19%) |
| FY2021 | 62.7× | — |
| FY2020 | 0.0× | — |
| FY2019 | 66.4× | 73.60% |
| FY2018 | 38.2× | 53.99% |
| FY2017 | 24.8× | 89.13% |
| FY2016 | 13.1× | 0.00% |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 19.7× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| Sep 2025 | 0.0× | — |
| 39 more quarters | Free account |
Against its own ten years
Low 0.0×
High 221×
Ten-year median
22.6×
Current reading's percentile
66
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| PACB Pacific Biosciences of California, Inc. compare | n/m |
| CTKB Cytek Biosciences, Inc. compare | n/m |
| BBNX Beta Bionics, Inc. compare | n/m |
| AHCO AdaptHealth Corp. compare | n/m |
| QDEL QuidelOrtho Corporation compare | n/m |
| KIDS OrthoPediatrics Corp. compare | n/m |
| INMD InMode Ltd. compare | 10.7× |
| BVS Bioventus Inc. compare | 12.3× |
| VREX VAREX IMAGING | 34.8× |
| Medical Devices industry median | 25.6× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)